Results 1 to 10 of about 37,435 (296)
European Journal of Case Reports in Internal Medicine, 2021 Gemfibrozil is a lipid-regulating agent used mainly to treat patients with hypertriglyceridaemia, especially those at risk for acute pancreatitis. Like any other pharmacological agent, gemfibrozil has known adverse effects, mainly gastrointestinal, such ...
Ashraf Ahmed +2 more
doaj +5 more sources
Pharmacologic management of nocturnal polyuria: a contemporary assessment of efficacy, safety, and progress toward individualized treatment [PDF]
Therapeutic Advances in Urology, 2021 This narrative review synthesizes current evidence on the medical management of nocturnal polyuria, including antidiuretic replacement therapy as well as other emerging modalities, with particular emphasis on areas of active investigation and future ...
Thomas F. Monaghan +3 more
openalex +2 more sources
Analysis of factors associated with polyuria in spinal surgery: a retrospective study [PDF]
BMC AnesthesiologyBackground Intraoperative urine output monitoring is an important indicator to judge patient volume, and perioperative polyuria can lead to a variety of complications, which seriously affect the quality of prognosis of patients.
Siqi Zhou +5 more
doaj +2 more sources
Decreased nitric oxide production is a novel therapeutic target for salt-induced nocturnal polyuria in aging [PDF]
Scientific ReportsNocturnal polyuria is a major cause of nocturia, which affects quality of life. Aging-related decreases in nitric oxide production have been reported to contribute to salt-induced nocturnal polyuria.
Takahiro Imanaka +11 more
doaj +2 more sources
Polyuria and cerebral vasospasm after aneurysmal subarachnoid hemorrhage [PDF]
BMC Neurology, 2015 BackgroundNatriuresis with polyuria is common after aneurysmal subarachnoid hemorrhage (aSAH). Previous studies have shown an increased risk of symptomatic cerebral vasospasm or delayed cerebral ischemia (DCI) in patients with hyponatremia and/or the ...
Robert Brown +5 more
openalex +2 more sources
International journal of clinical practice, 2016 To evaluate the safety and efficacy of low‐dose desmopressin in elderly men with and without nocturnal polyuria (NP) in real‐life practice.
S.-L. Chen +3 more
openalex +2 more sources
Oxidative stress-induced NCC activation in the development of nocturnal polyuria in mice: Therapeutic potential of a sustained hydrogen-releasing silicon-based agent [PDF]
Biochemistry and Biophysics ReportsNocturnal polyuria is a prevalent condition associated with significant deterioration in quality of life and increased risk of mortality. Despite its clinical relevance, the underlying pathogenesis is poorly understood, and existing therapies have ...
Yosuke Sekii +12 more
doaj +2 more sources
Poiseuille’s law in polyuria [PDF]
Pediatric Nephrology, 2014 Dear Sir,In their recent paper, Caletti et al. describe urinary tract find-ings in children with nephrogenic diabetes insipidus (NDI)and show that seven out of ten patients have renal pelvicdilatation that improved or even normalized during follow-up[1].Treatmentwithalowosmolardietincombinationwithdiuretics and indomethacin reduced the urine output ...
Michiel F. Schreuder +1 more
openalex +6 more sources
Central diabetes insipidus following COVID-19 mRNA vaccination: a case report [PDF]
Kosin Medical Journal, 2023 The coronavirus disease 2019 (COVID-19) has been a major public health emergency worldwide. Vaccines were rapidly developed and approved to prevent the spread of viral infection. However, various side effects of the COVID-19 messenger RNA (mRNA) vaccines
Min-Young Kim +9 more
doaj +1 more source
Polyuria following an overdose
International Journal of Critical Illness and Injury Science, 2013 Case report detailing the occurrence of diabetes insipidus in a 42-year-old man admitted to the intensive treatment unit (ITU) following an overdose. Whilst on ITU, he was sedated with propofol. Cessation of treatment with propofol coincided with resolution of the polyuria.
Angela B. Collins, N. White
openalex +5 more sources